These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31151747)

  • 1. Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target.
    Unver N
    Cytokine Growth Factor Rev; 2019 Dec; 50():13-18. PubMed ID: 31151747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte trafficking: Can we bring the fight to the tumor?
    Pachynski R; Nazha J; Kohrt H
    Discov Med; 2016 Mar; 21(115):205-12. PubMed ID: 27115171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory chemokines and metastasis--tracing the accessory.
    Borsig L; Wolf MJ; Roblek M; Lorentzen A; Heikenwalder M
    Oncogene; 2014 Jun; 33(25):3217-24. PubMed ID: 23851506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
    Nagarsheth N; Wicha MS; Zou W
    Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy.
    Jung H; Paust S
    Front Immunol; 2024; 15():1443366. PubMed ID: 39114657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
    Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstacles to T cell migration in the tumor microenvironment.
    Nicolas-Boluda A; Donnadieu E
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():22-30. PubMed ID: 30961814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC chemokine receptor 5: the interface of host immunity and cancer.
    de Oliveira CE; Oda JM; Losi Guembarovski R; de Oliveira KB; Ariza CB; Neto JS; Banin Hirata BK; Watanabe MA
    Dis Markers; 2014; 2014():126954. PubMed ID: 24591756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.
    Argyle D; Kitamura T
    Front Immunol; 2018; 9():2629. PubMed ID: 30483271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-education of macrophages as a therapeutic strategy in cancer.
    Kowal J; Kornete M; Joyce JA
    Immunotherapy; 2019 Jun; 11(8):677-689. PubMed ID: 31088236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages: role in cancer development and therapeutic implications.
    Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
    Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving homing in T cell therapy.
    Vignali D; Kallikourdis M
    Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: The Role of Chemoattractants in the Tumor Microenvironment.
    Bernardini G; Zabel BA
    Front Immunol; 2019; 10():2671. PubMed ID: 31781129
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.
    Tsukamoto H; Komohara Y; Oshiumi H
    Hum Cell; 2021 Jul; 34(4):1031-1039. PubMed ID: 33905102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer.
    Francis L; Guo ZS; Liu Z; Ravindranathan R; Urban JA; Sathaiah M; Magge D; Kalinski P; Bartlett DL
    Oncotarget; 2016 Apr; 7(16):22174-85. PubMed ID: 26956047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.
    Saxena S; Singh RK
    Cancer Metastasis Rev; 2021 Jun; 40(2):447-476. PubMed ID: 33959849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
    Ngambenjawong C; Gustafson HH; Pun SH
    Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines in cancer.
    Chow MT; Luster AD
    Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.